Search Results - "Tanussiya, Shyrar"
-
1
Transmission dynamics, clinical characteristics and sero-surveillance in the COVID-19 outbreak in a population dense area of Colombo, Sri Lanka April- May 2020
Published in PloS one (08-11-2021)“…Background The transmission dynamics of SARS-CoV-2 varies depending on social distancing measures, circulating SARS-CoV-2 variants, host factors and other…”
Get full text
Journal Article -
2
Are viral loads in the febrile phase a predictive factor of dengue disease severity?
Published in BMC infectious diseases (05-11-2024)“…Abstract Background As many studies have shown conflicting results regarding the extent of viraemia and clinical disease severity, we sought to investigate if…”
Get full text
Journal Article -
3
Seroprevalence of SARS-CoV-2 Infection in the Colombo Municipality Region, Sri Lanka
Published in Frontiers in public health (12-11-2021)“…Background: As the Municipality Council area in Colombo (CMC) experienced the highest number of cases until the end of January 2021, in Sri Lanka, we carried…”
Get full text
Journal Article -
4
Antibody and memory B cell responses to the dengue virus NS1 antigen in individuals with varying severity of past infection
Published in Immunology (01-09-2023)“…To further understand the role of NS1‐specific antibodies (Abs) in disease pathogenesis, we compared neutralizing antibody levels (Nabs), NS1‐Ab levels, IgG…”
Get full text
Journal Article -
5
Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri Lanka
Published in The Journal of immunology (1950) (01-12-2021)“…Abstract Due to limited access to vaccines, many countries have only administered a single dose of the AZD1222, whereas the dosage intervals have increased ≥4…”
Get full text
Journal Article -
6
Immune responses to Sinopharm/BBIBP‐CorV in individuals in Sri Lanka
Published in Immunology (01-10-2022)“…As there are limited data of the immunogenicity of the Sinopharm/BBIBP‐CorV in different populations, antibody responses against different SARS‐CoV‐2 variants…”
Get full text
Journal Article -
7
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac)
Published in Scientific reports (02-02-2022)“…As the first dose of Gam-COVID-Vac, is currently used as a single dose vaccine in some countries, we investigated the immunogenicity of this at 4 weeks (327…”
Get full text
Journal Article -
8
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
Published in Immunity, Inflammation and Disease (01-06-2022)“…Background To determine the kinetics and persistence of immune responses following the Sinopharm/BBIBP‐CorV, we investigated immune responses in a cohort of…”
Get full text
Journal Article -
9
Transmission dynamics, clinical characteristics and sero-surveillance in the COVID-19 outbreak in a population dense area of Colombo, Sri Lanka April- May 2020
Published in PloS one (01-01-2021)“…Background The transmission dynamics of SARS-CoV-2 varies depending on social distancing measures, circulating SARS-CoV-2 variants, host factors and other…”
Get full text
Journal Article -
10
Identifying an Immunodominant Epitope of Dengue Non-Structural Protein 1 (NS1) in Acute Secondary Dengue Infections for Vaccine Development or Development of Treatment Modalities
Published in 2020 From Innovation to Impact (FITI) (15-12-2020)“…Dengue infection is a rapidly emerging disease with no licensed treatment or vaccine available. It is currently unclear whether antibody responses to dengue…”
Get full text
Conference Proceeding